Probiodrug AG Strengthens Management Team and Expands Global Reach with Appointments of Ronald Black and Inge Lues
1/23/2013 7:14:57 AM
More...
|
Probiodrug AG, Collaborators Explain Interplay of Key Suspects in Alzheimer's Disease
5/3/2012 12:13:38 PM
More...
|
Probiodrug AG to Present at the 30th JP Morgan Annual Healthcare Conference
1/6/2012 10:57:07 AM
More...
|
Probiodrug AG Raises Additional EUR $15 Million to Advance Its Clinical Program
1/4/2012 6:40:17 AM
More...
|
Probiodrug AG Announces Top-Line Results of the First Clinical Study of PQ912 for Treatment of Alzheimer's Disease
11/14/2011 7:57:57 AM
More...
|
Probiodrug AG and Its Collaborators Will Present Novel Insights into the Pathophysiology of Alzheimer's Disease at Society For Neuroscience's Neuroscience 2011 Conference in Washington, D.C.
11/9/2011 12:07:57 PM
More...
|
Probiodrug AG and its Collaborators Will Present Novel Insights into the Pathophysiology of Alzheimer's Disease and Biomarkers at AD/PD 2011 in Barcelona
3/8/2011 10:22:07 AM
More...
|
Probiodrug AG Appoints Prof Cynthia Lemere to its Scientific Advisory Board
11/15/2010 1:44:56 PM
More...
|
Probiodrug AG Appoints Kumar Srinivasan as Chief Business Officer
9/13/2010 3:24:35 PM
More...
|
Probiodrug AG Announces Supervisory Board Changes
6/14/2010 8:18:50 AM
More...
|
|